Pharmaceuticals/Chemicals
Nebivolol
Bystolic
β1-selective blocker with nitric-oxide-mediated vasodilation; BP management on-cycle.
Pharmacokinetic summary
- Model tier
- Advanced (t½ + Cmax + Tmax + F)
- Half-life
- 0.7 days
- Cmax
- 11.6 ng/mL
- Tmax
- 0.1 days
- Bioavailability
- 54%
- Typical dose
- 2.5–20 mg